推荐产品
质量水平
方案
≥98% (HPLC)
表单
powder
旋光性
[α]/D +120 to +130°, c = 1.0 in water
储存条件
desiccated
颜色
white to light brown
溶解性
H2O: ≥20 mg/mL
创始人
Daiichi-Sankyo
储存温度
−20°C
SMILES字符串
O.[Na+].C[C@@H](O)C1C2SC(C3CCCO3)=C(N2C1=O)C([O-])=O
InChI
1S/C12H15NO5S.Na.H2O/c1-5(14)7-10(15)13-8(12(16)17)9(19-11(7)13)6-3-2-4-18-6;;/h5-7,11,14H,2-4H2,1H3,(H,16,17);;1H2/q;+1;/p-1/t5-,6-,7+,11-;;/m1../s1
InChI key
FHSVCMPZCIOKGW-VIDQLUEFSA-M
一般描述
法罗培南钠水合物属于口服处方的青霉类抗生素。具有头孢菌素抗性的肠杆菌科细菌感染易受法罗培南的影响。法罗培南可能是治疗由广谱β-内酰胺酶（ESBL）产生细菌引起的尿路感染的一种有效的抗生素。
生化/生理作用
法罗培南钠是一种超广谱、耐受β-内酰胺酶的β-内酰胺抗生素，对革兰氏阳性和革兰氏阴性细菌均具有活性。
特点和优势
该化合物由Daiichi-Sankyo开发。要浏览其他药物开发化合物和批准的药物/候选药物列表，单击此处。
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
新产品
从最新的版本中选择一种：
分析证书(COA)
Lot/Batch Number
S Furukawa et al.
The Japanese journal of antibiotics, 48(2), 210-219 (1995-02-01)
1. SY5555 dry syrup (powder which is dissolved before use) was administered to 25 patients with bacterial infections (6 cases of bronchitis, 2 cases of bronchopneumonia, 1 case of pertussis, 3 cases of scarlet fever, 5 cases of tonsillitis, 3
Faropenem, a new oral penem: antibacterial activity against selected anaerobic and fastidious periodontal isolates.
Milazzo I, et al.
The Journal of Antimicrobial Chemotherapy, 51(3), 721-725 (2003)
S K Spangler et al.
Antimicrobial agents and chemotherapy, 38(11), 2599-2604 (1994-11-01)
The National Committee for Clinical Laboratory Standards agar dilution method was used to compare the in vitro activity of WY-49605 (also called SUN/SY 5555 and ALP-201), a new broad-spectrum oral penem, to those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime
H Wakiguchi et al.
The Japanese journal of antibiotics, 48(2), 229-237 (1995-02-01)
Clinical effects of SY5555 dry syrup, a new oral penem antibiotic, were analysed in 20 children with various bacterial infections. Ages of the patients varied from 8 months to 14 years. Doses of SY5555 were varied from 12.8 mg/kg/day to
M G Cormican et al.
The Journal of antimicrobial chemotherapy, 35(4), 535-539 (1995-04-01)
Furopenem is a novel orally active penem. In this study, furopenem was highly active in vitro against Streptococcus pneumoniae (MIC90 0.03 mg/L), Haemophilus influenzae (MIC90, 2 mg/L), and Moraxella catarrhalls (MIC90, 0.5 mg/L). Its activity was not reduced by a
商品
Bioactive small molecules for immune system signaling target identification/validation and antibiotics, antivirals, and antifungals offered.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门